Patient safety is foremost in the practice of dermatology and board certified dermatologists take adverse effects seriously. Although still very early in the vaccination process, this guidance is meant to be informational and helpful as we move forward during pandemic recovery efforts.
ROLLING MEADOWS, Ill. (PRWEB)
December 29, 2020
The American Society for Dermatologic Surgery (ASDS) crafted, “Guidance Regarding SARS-CoV-2 mRNA Vaccine Side Effects in Dermal Filler Patients.” This guidance shares data from the U.S. Food and Drug Administration (FDA) on reactions associated with the mRNA vaccine and provides perspective for patients and practitioners regarding the incidence of reactions based on available data to date.
The Soft-tissue Fillers Guideline Task Force will soon be publishing a multispecialty evidence-based clinical guideline on the prevention and treatment of adverse events from soft-tissue fillers. When reactions from the SARS-CoV-2 mRNA vaccine were reported in dermal filler patients, members of the task force and ASDS leadership reviewed the available data to create a vaccine guidance. The authors include:
- Mathew Avram, MD, JD, ASDS President
- Sue Ellen Cox, MD, ASDS President-Elect and Soft-tissue Fillers Guideline Task Force Member
- Vince Bertucci, MD, FRCPC, ASDS Vice President
- Derek Jones, MD, Soft-tissue Fillers Guideline Task Force Chair
- Kavita Mariwalla, MD, ASDS Secretary
Patients already treated with dermal fillers should not be precluded from receiving vaccines of any kind, and correspondingly, patients who have had vaccines should not be precluded from receiving dermal fillers in the future. ASDS members will continue to evaluate and monitor developments. For those rare reactions, effects are temporary and respond to standard treatments or often resolve without treatment.
“Patient safety is foremost in the practice of dermatology and board certified dermatologists take adverse effects seriously,” said ASDS President Mathew Avram, MD, JD. “Although still very early in the vaccination process, this guidance is meant to be informational and helpful as we move forward during pandemic recovery efforts.”
Visit http://bit.ly/ASDS-covid-19-vaccine-guidance to access the guidance document.
About the American Society for Dermatologic Surgery
The American Society for Dermatologic Surgery (ASDS) is the largest specialty organization exclusively representing dermatologic surgeons who have unique training and experience to treat the health, function and beauty of skin throughout every stage of life. ASDS members are recognized as leaders in the field of cosmetic and medically necessary skin surgery. They also are pioneers in the field; many are involved in the clinical studies that bring popular treatments to revitalize skin and fill and diminish wrinkles to the forefront. Their work has helped create and enhance many of the devices that remove blemishes, hair and fat, and tighten skin. Dermatologic surgeons also are experts in skin cancer prevention, detection and treatment. As the incidence of skin cancer rises, dermatologic surgeons are committed to taking steps to minimize the life-threatening effects of this disease. For more information, visit https://asds.net.
Share article on social media or email: